Skip to main content
IRTC
NASDAQ Industrial Applications And Services

iRhythm Holdings Reports Strong Q1 2026 Results with 26% Revenue Growth and Positive Adjusted EBITDA

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$126
Mkt Cap
$4.243B
52W Low
$105
52W High
$212
52W Position info
20% above low
Off High info
41% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

IRTC sits 20% above its 52-week low of $105 on elevated volume (1.8× avg).

Summary

iRhythm Holdings, Inc. reported strong first-quarter 2026 financial results, with revenue increasing 26% year-over-year and Adjusted EBITDA turning positive, alongside updates on ongoing legal proceedings and a new equity incentive plan.


Key Events · Earnings and Guidance · IRTC

  • Strong Q1 2026 Financial Performance

    Revenue increased by 26% to $199.4 million for the three months ended March 31, 2026, compared to $158.7 million in the prior year. Net loss significantly reduced to $13.9 million from $30.7 million, and Adjusted EBITDA turned positive at $14.1 million, up from a loss of $2.6 million year-over-year.

  • New 2026 Equity Incentive Plan Approved

    The company adopted a new 2026 Equity Incentive Plan, reserving 1,690,000 shares for future grants. This represents approximately 5.14% of the current outstanding shares, providing a moderate potential for dilution.

  • Updates on Legal and Regulatory Proceedings

    The company provided updates on several ongoing legal matters, including a securities class action lawsuit (with mediation discussions held in April 2026), DOJ grand jury subpoenas and civil investigative demands, and patent infringement lawsuits from Welch Allyn and Bardy Diagnostics. The outcomes of these matters remain uncertain.

  • Holding Company Transaction Completed

    The corporate holding company structure, which resulted in iRhythm Holdings, Inc. becoming the new parent, was implemented on January 12, 2026. This transaction was previously disclosed and is reiterated in this filing.


Analysis · IRTC · Industrial Applications And Services

iRhythm Holdings, Inc. delivered a strong first quarter, showcasing robust revenue growth and a significant improvement in profitability. The company's revenue increased by 26% year-over-year, and it achieved positive Adjusted EBITDA, a notable turnaround from a loss in the prior year. This financial performance indicates strong operational execution and demand for its services. While the company continues to navigate multiple ongoing legal and regulatory challenges, the positive financial results provide a strong foundation. The approval of a new equity incentive plan, while moderately dilutive, is a standard measure for employee compensation and retention.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IRTC was trading at $126.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $105.00 to $212.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IRTC - Latest Insights

IRTC
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $88.68
Real-time Price: $90.83 info
Change: +$2.15 (+2%) info
Market Cap: $3.054B info
IRTC
Nov 06, 2026, 1:07 PM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $89.20
Real-time Price: $90.83 info
Change: +$1.63 (+2%) info
Market Cap: $3.054B info
IRTC
Nov 05, 2026, 5:20 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $110.00
Real-time Price: $90.83 info
Change: -$19.17 (-17%) info
Market Cap: $3.054B info
IRTC
Nov 05, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $117.50
Real-time Price: $90.83 info
Change: -$26.67 (-23%) info
Market Cap: $3.054B info
IRTC
Nov 05, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $130.19
Real-time Price: $90.83 info
Change: -$39.36 (-30%) info
Market Cap: $3.054B info